If you have been reading about neurotrophic factor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-06-08. Numbers and descriptions here follow the published literature rather than marketing material.
Semax is a synthetic heptapeptide developed in the Soviet Union during the 1980s by researchers at the Institute of Molecular Genetics in Moscow. It was designed as a truncated analog of adrenocorticotropic hormone, retaining only the fragment spanning residues four through ten. Investigators sought a peptide that would preserve the cognitive effects associated with ACTH while eliminating the hormonal stimulation of the adrenal cortex. The compound entered clinical use in Russia during the following decade.
Russian regulatory authorities approved the peptide for nasal administration, and it remains listed in the national pharmacopoeia under several trade names. Documented indications include acute ischemic stroke, transient ischemic attacks, traumatic brain injury, and certain ophthalmological and neurological conditions. Physicians also prescribe it for cognitive complaints in older patients, although the evidence base for that use is thinner. Outside Russia and a few neighboring states, the substance is not an approved medicine and is sold instead as a research chemical.
Proposed mechanisms center on neurotrophic signaling rather than on classical melanocortin receptor activation. Rodent experiments have reported shifts in the expression of brain-derived neurotrophic factor and nerve growth factor after administration, together with changes in the associated receptor systems. Several authors argue that the peptide acts largely through its degradation products and their interaction with peptidergic pathways, but this remains a hypothesis rather than a settled finding. No single molecular target has been identified in a way that the field broadly accepts.
Published research covers ischemic stroke, traumatic brain injury, cognitive impairment, optic nerve conditions and attention-related measures. Much of the human evidence comes from small trials conducted in one country, which limits how far the results generalize. Animal models supply the larger share of the data, and effects seen in rodents do not transfer automatically to people. Reviews have noted that methodological reporting is often incomplete, making it difficult to pool results or compare treatment schedules across studies.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic heptapeptide | Analog of an ACTH fragment |
| Amino acid length | Seven residues | Met-Glu-His-Phe-Pro-Gly-Pro |
| Origin | Moscow, 1980s | Institute of Molecular Genetics |
| Approved regions | Russia and some neighboring states | Not cleared in Western markets |
| Common trade names | Multiple national brands | Sold as a nasal formulation |
Clinical evidence consists largely of small trials with modest sample sizes, often without independent replication. Reported endpoints include cognitive scores, recovery after stroke, and visual function, but study designs vary widely and few trials meet contemporary reporting standards. Systematic reviewers have noted a high risk of bias in several of these reports. No large multicenter trial conducted outside Russia has been published. The compound is therefore best described as investigational in most jurisdictions, with its clinical role still unresolved.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its chain combines the first seven residues of corticotropin with a C-terminal proline-glycine-proline extension, a modification intended to slow enzymatic breakdown. The free peptide has a molecular mass near 813.9 daltons. It belongs to the class of ACTH-derived fragments studied for central nervous system activity rather than for adrenal steroid stimulation. This structural relationship to a natural hormone fragment is the usual starting point for describing the compound in the literature.
Once dissolved, the peptide is considerably less stable than the solid. Aqueous solutions are usually prepared at neutral to slightly acidic pH, filtered, and divided into single-use aliquots before freezing. Repeated freeze-thaw cycles are a common cause of avoidable loss and are best prevented by never refreezing a thawed aliquot. Adsorption to plastic and glass surfaces can lower the measured concentration of dilute solutions, particularly below roughly 0.1 mg/mL. Buffer choice, salt content, and container material all influence how much peptide remains detectable after storage.
Identity and purity are established with standard peptide methods. Reversed-phase HPLC with ultraviolet detection near 214 nm resolves the parent peak from deletion and truncation byproducts, and reports typically quote a main-peak percentage. Mass spectrometry by electrospray or MALDI-TOF confirms the expected molecular mass, while amino acid analysis or peptide mapping can verify composition when the sequence itself is in question. A certificate of analysis that pairs a chromatogram with a mass spectrum is more informative than a purity figure alone. Counter-ion content and residual solvents are separate specifications and are frequently omitted.
Hemoglobin S/ beta thalassemia: (see above). Hemoglobin S/ hemoglobin C (Hemoglobin SC disease) occurs when an individual inherits one gene for hemoglobin S (sickle cell) and one gene for hemoglobin C, The symptoms are very similar to sickle cell disease.
Dimethyltryptamine (DMT), also known as N,N-dimethyltryptamine (N,N-DMT), is a serotonergic hallucinogen and investigational drug of the tryptamine family that occurs naturally in many plants and animals. DMT is used as a psychedelic drug and prepared by various cultures for ritual purposes as an entheogen. DMT has a rapid onset, intense effects, and a relatively short duration of action. For those reasons, DMT was known as the "businessman's trip" during the 1960s in the United States, as a user could access the full depth of a psychedelic experience in considerably less time than with other substances such as LSD or psilocybin mushrooms. DMT can be inhaled or injected and its effects depend on the dose, as well as the mode of administration. When inhaled or injected, the effects last about five to fifteen minutes. Effects can last three hours or more when orally ingested along with a monoamine oxidase inhibitor (MAOI), such as the ayahuasca brew of many native Amazonian tribes. DMT induces intense, often indescribable subjective experiences involving vivid visual hallucinations, altered sensory perception, ego dissolution, and encounters with seemingly autonomous entities. DMT is generally considered non addictive with low dependence and having little to no tolerance build-up with short-acting routes, but it may cause acute psychological distress or cardiovascular effects, especially in predisposed individuals. DMT was first synthesized in 1931.
Narrated by Paul Barry, produced by Daryl Karp, directed by Richard Smith, an Australian production, made by ABC 25 September Cleared for Take-off, the years leading to the first flight of the Boeing 777, planned for May 1995; testing the Boeing 777 APU in cold weather in Alaska; Boeing put £5bn into the testing; Alan Mulally, head of the 777 team; the evangelical management process of 'Working Together', to avoid secrecy; Ronald Ostrowski, director of engineering on the 777; the engines cost 20% of the total cost; Granville Frazier of propulsion; the ETOPS standard for twin-engined aircraft; Chester Ekstrand; the first ever 747 is fitted with a 777 testbed engine; the Pratt Whitney test rig at the Aero-propulsion Systems Test Facility at Tullahoma, Tennessee; Baldey Mehta of the 777 engine; John Cashman, the chief 777 test pilot; the 777 engine testbed has an engine surge, on take off; Thomas Davenport, head of the 777 program for Pratt Whitney; Rocky Thomas of Propulsion; the 777 fuselage is pressurised in January 1994, for the first time from 5 psi to 12 psi; Philip M. Condit; Neil Standal of the fabrication division; Jim McWha of flight testing; Lyle Eveland, head of factory operations; the 777 has its first flight on 12 June 1994, to test the aircraft stability; Frank Shrontz, head of Boeing.
Sources: en.wikipedia.org
Dogs are prone to have adverse allergic reactions to food similar to human beings. The most common symptoms of food allergies in dogs include rashes, swelling, itchy or tender skin, and gastrointestinal upsets such as uncontrollable bowel movements and soft stools. Certain ingredients in dog food can elicit these allergic reactions. Specifically, the reactions are understood to be initiated by the protein ingredients in dog food, with sources such as beef, chicken, soy, and turkey being common causes of these allergic reactions. A number of "novel protein" dog foods are available that claim to alleviate such allergies in dogs. Hypoallergenic diets for dogs with food allergies consist of either limited ingredients, novel proteins, or hydrolyzed proteins. Limited ingredients make it possible to identify the suspected allergens causing these allergic reactions, as well as making it easy to avoid multiple ingredients if a canine is allergic to more than one. In novel protein recipes, manufacturers use ingredients which are less likely to cause allergic reactions in dogs such as lamb, fish, and rice. Hydrolyzed proteins do not come from a novel source; they could originate from chicken or soy for example. Hydrolyzed proteins become novel when they are broken apart into unrecognizable versions of themselves, making them novel to allergic gastrointestinal tracts.
=== Erythropoietic protoporphyria === High doses of β-carotene (up to 180 mg per day) may be used as a treatment for erythropoietic protoporphyria, a rare inherited disorder of sunlight sensitivity, without toxic effects.
Even during digestion, in general, one or two hours following a meal, insulin release from the pancreas is not continuous, but oscillates with a period of 3–6 minutes, changing from generating a blood insulin concentration more than about 800 p mol/l to less than 100 pmol/L (in rats). This is thought to avoid downregulation of insulin receptors in target cells, and to assist the liver in extracting insulin from the blood. This oscillation is important to consider when administering insulin-stimulating medication, since it is the oscillating blood concentration of insulin release, which should, ideally, be achieved, not a constant high concentration. This may be achieved by delivering insulin rhythmically to the portal vein, by light activated delivery, or by islet cell transplantation to the liver.
Sources: en.wikipedia.org
== See also == Tigray People's Liberation Front Interim Regional Administration of Tigray Ethiopia–Tigray peace agreement Tigray War Debretsion Gebremichael Tadesse Werede Getachew Reda Politics of Ethiopia
=== Other uses in science and technology === Link (Mars), a rock outcrop Link or linking col, used in determining topographic prominence Telecommunications link, communication channel between two or more devices LINK, a spacecraft used in the Swift rescue mission
The engine was connected to the motor by a clutch and the motor in turn connected to the propeller shaft by another clutch. With only the rear clutch engaged, the electric motor could drive the propeller, as required for fully submerged operation. With both clutches engaged, the combustion engine could drive the propeller, as was possible when operating on the surface or, at a later stage, when snorkeling. The electric motor would in this case serve as a generator to charge the batteries or, if no charging was needed, be allowed to rotate freely. With only the front clutch engaged, the combustion engine could drive the electric motor as a generator for charging the batteries without simultaneously forcing the propeller to move. The motor could have multiple armatures on the shaft, which could be electrically coupled in series for slow speed and in parallel for high speed (these connections were called "group down" and "group up", respectively).
Neptunium (93Np) is usually considered an artificial element, although trace quantities are found in nature, so a standard atomic weight cannot be given. Like all trace or artificial elements, it has no stable isotopes. The first isotope to be synthesized and identified was 239Np in 1940, produced by bombarding 238U with neutrons to produce 239U, which then underwent beta decay to 239Np. Trace quantities are found in nature from neutron capture reactions by uranium atoms, a fact not discovered until 1951. Twenty-five neptunium radioisotopes have been characterized, with the most stable being 237Np with a half-life of 2.144 million years, 236Np with a half-life of 153,000 years, and 235Np with a half-life of 396.1 days. All of the remaining radioactive isotopes have half-lives that are less than 4.5 days, and the majority of these have half-lives that are less than 50 minutes. This element also has five meta states, with the most stable being 236mNp (t1/2 22.5 hours). The isotopes of neptunium range from 219Np to 244Np, though the intermediate isotope 221Np has not yet been observed. The primary decay mode for nuclei lighter than the most stable isotope, 237Np, is electron capture (and also alpha emission), and the primary mode after is beta emission. The primary decay products for nuclei lighter than 237Np are isotopes of uranium and protactinium, and the primary products after are isotopes of plutonium. Neptunium is the heaviest element for which the location of the proton drip line is known; the lightest proton-bound isotope is 220Np.
Sources: en.wikipedia.org
It originated at the Institute of Molecular Genetics in Moscow during the 1980s. The work was carried out by a Russian research group that specialized in peptide neuropharmacology.
It is registered as a medicine in Russia and has been used clinically there for decades. No regulatory agency in Western Europe or North America has approved it for any indication.
Semax corresponds to the four-to-ten fragment of adrenocorticotropic hormone. Because it omits the first three residues, it lacks the adrenal-stimulating action of the full hormone.
The main proposal is modulation of neurotrophic factors such as brain-derived neurotrophic factor, supported largely by animal experiments. Receptor-level targets have not been firmly established. Most reviews describe the mechanism as only partially characterized.